Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 60 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Georgianos, Panagiotis I [Clear All Filters]
Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?.
Hypertens Res. 46(4), 890-892.
(2023). VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial..
PLoS One. 17(8), e0273102.
(2022). Therapeutic Advances in Diabetic Kidney Disease..
Int J Mol Sci. 24(3),
(2023). Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?.
Expert Opin Pharmacother.
(2023). SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?.
Curr Med Chem. 26(29), 5564-5578.
(2019). Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness..
J Clin Hypertens (Greenwich). 16(7), 475-6.
(2014). Pulse wave velocity assessment for cardiovascular risk prognostication in ESKD: weighing recent evidence..
Curr Vasc Pharmacol.
(2020). Pro: Should we move to more frequent haemodialysis schedules?.
Nephrol Dial Transplant. 30(1), 18-22.
(2015). Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis..
Int Urol Nephrol. 54(9), 2327-2334.
(2022). Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis..
Am J Hypertens. 35(11), 918-922.
(2022). Prevalence and control of hypertension among patients on haemodialysis..
Eur J Clin Invest. 50(10), e13292.
(2020). PPAR-γ agonism for cardiovascular and renal protection..
Cardiovasc Ther. 29(6), 377-84.
(2011). Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents..
Expert Opin Investig Drugs. 21(8), 1089-106.
(2012). Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension..
Am J Hypertens. 22(10), 1070-5.
(2009). Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses..
J Clin Hypertens (Greenwich). 21(7), 919-921.
(2019). Opponent's comment..
Nephrol Dial Transplant. 30(1), 27-8.
(2015). Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues..
J Clin Hypertens (Greenwich). 18(3), 197-9.
(2016). Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence..
Curr Vasc Pharmacol. 15(6), 599-606.
(2017). Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions..
J Clin Hypertens (Greenwich). 21(2), 249-251.
(2019). The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria..
J Hypertens. 40(7), 1432-1433.
(2022). Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report..
BMC Nephrol. 19(1), 293.
(2018). Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022). Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis..
Am J Kidney Dis. 59(3), 434-8.
(2012). Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed..
J Am Soc Hypertens. 12(4), 242-247.
(2018). Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients..
Am J Nephrol. 34(5), 407-14.
(2011).